All signs continue to point forward for Biogen’s initial foray into lupus, as litifilimab elicited clear or almost clear skin ...
A Phase I study of the investigational CAR-T cell therapy prulacabtagene leucel (prula-cel) found that some people with SLE, including those with lupus nephritis (LN), achieved remission and ...
A multicenter study led by researchers at Sultan Qaboos University has found that patients with a rare inherited form of ...
The Star on MSN
When lupus turned against her body
For Teresa Kariuki, 32, illness began quietly. As a child growing up in Aguthi ward, Gichira sublocation, Nyeri county, she was an ordinary schoolgirl, obedient and determined to complete her ...
The Lupus Research Alliance (LRA), the world's largest private funder of lupus research, will unite dedicated lupus champions ...
It wasn’t until a kind nurse noticed what was going on that this teacher finally got a diagnosis and treatment.
Background SLE is a complex autoimmune condition requiring evaluation across disease activity, permanent damage and ...
Adicet Bio (NASDAQ:ACET) reported positive clinical data for prula-cel, its investigational allogeneic gamma delta CAR-T cell therapy, in patients with systemic lupus erythematosus, or SLE, including ...
Fever, fatigue and joint pain may signal a lupus flare or an infection. Learn how rheumatology specialists distinguish the ...
More than 80% of adults with lupus used dietary supplements, while nearly 30% had combinations with potential medication ...
Michelle Min, MD, MS, reviewed best practices for managing cutaneous lupus and discussed emerging therapies practitioners ...
WKRN Nashville on MSN
Tennessee walk to end lupus
The Lupus Foundation of America is encouraging Tennesseans to get involved with the Tennessee Walk to End Lupus Now on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results